These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Central nervous system abnormalities in asymptomatic young patients with Sbeta-thalassemia. Zafeiriou DI, Prengler M, Gombakis N, Kouskouras K, Economou M, Kardoulas A, Tsantali C, Dimitriadis A, Athanasiou M, Kirkham FJ. Ann Neurol; 2004 Jun; 55(6):835-9. PubMed ID: 15174017 [Abstract] [Full Text] [Related]
4. Hypercoagulable state in five thalassemia intermedia patients. Bhattacharyya M, Kannan M, Chaudhry VP, Mahapatra M, Pati H, Saxena R. Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195 [Abstract] [Full Text] [Related]
5. Plasma protein Z and protein C inhibitors and their role in hypercoagulability of thalassemia. Del Vecchio GC, Nigro A, Giordano P, Schettini F, Altomare M, Pietrapertosa A, De Mattia D. Acta Haematol; 2007 Oct; 118(3):136-40. PubMed ID: 17804900 [Abstract] [Full Text] [Related]
6. Congenital thrombotic risk factors in beta-thalassemia. Sipahi T, Kara A, Kuybulu A, Egin Y, Akar N. Clin Appl Thromb Hemost; 2009 Oct; 15(5):581-4. PubMed ID: 18480081 [Abstract] [Full Text] [Related]
9. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. Zhang D, Hao J, Yang N. J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413 [Abstract] [Full Text] [Related]
10. Neurophysiologic and intellectual evaluation of beta-thalassemia patients. Economou M, Zafeiriou DI, Kontopoulos E, Gompakis N, Koussi A, Perifanis V, Athanassiou-Metaxa M. Brain Dev; 2006 Jan; 28(1):14-8. PubMed ID: 15925466 [Abstract] [Full Text] [Related]
11. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Heller MV, Marta RF, Sturk A, Maiztegui JI, Hack CE, Cate JW, Molinas FC. Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817 [Abstract] [Full Text] [Related]
14. Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin. Huang Y, Long Y, Deng D, Liu Z, Liang H, Sun N, Xu Y, Lai Y, Cheng P. Thromb Res; 2018 Dec; 172():61-66. PubMed ID: 30384036 [Abstract] [Full Text] [Related]
16. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Koutroubakis IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki M, Kouroumalis EA, Manousos ON. Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581 [Abstract] [Full Text] [Related]
17. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major. Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M. Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606 [Abstract] [Full Text] [Related]
18. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T, von Lessen A, Welters I, Wagner RM, Ruwoldt R, Boldt J, Hempelmann G. Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [Abstract] [Full Text] [Related]
19. Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status. Natesirinilkul R, Charoenkwan P, Nawarawong W, Boonsri S, Tantivate P, Wongjaikum S, Manowong S, Sanguansermsri T. Thromb Res; 2016 Apr; 140():125-131. PubMed ID: 26971311 [Abstract] [Full Text] [Related]
20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C. Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]